Your browser doesn't support javascript.
loading
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.
Seminario-Vidal, Lucia; Kroshinsky, Daniela; Malachowski, Stephen J; Sun, James; Markova, Alina; Beachkofsky, Thomas M; Kaffenberger, Benjamin H; Ergen, Elizabeth N; Mauskar, Melissa; Bridges, Alina; Calhoun, Cody; Cardones, Adela R; Chen, Steven T; Chodosh, James; Cotliar, Jonathan; Davis, Mark D P; DeNiro, Katherine L; Dominguez, Arturo R; Eljure-Téllez, Juliana; Femia, Alisa; Fox, Lindy P; Guda, Anisha; Mitchell, Caroline; Mostaghimi, Arash; Ortega-Loayza, Alex G; Owen, Cindy; Pasieka, Helena; Rahnama-Moghadam, Sahand; Saeed, Hajirah N; Saunderson, Rebecca B; Shanbhag, Swapna; Sharon, Victoria R; Strowd, Lindsay; Venkatesh, Samantha; Wanat, Karolyn A; Wetter, David A; Worswick, Scott; Micheletti, Robert G.
Afiliação
  • Seminario-Vidal L; Department of Dermatology, University of South Florida, Morsani College of Medicine, Tampa, Florida; Cutaneous Oncology Program, H. Lee Moffitt Cancer Center, Tampa, Florida. Electronic address: luciasem@usf.edu.
  • Kroshinsky D; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Malachowski SJ; Department of Internal Medicine, Medical College of Wisconsin Affiliated Hospitals, St. Joseph's Hospital, Milwaukee, Wisconsin.
  • Sun J; Cutaneous Oncology Program, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Beachkofsky TM; Department of Dermatology, Uniformed Services University, Bethesda, Maryland.
  • Kaffenberger BH; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Ergen EN; Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Mauskar M; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Bridges A; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • Calhoun C; Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Cardones AR; Department of Dermatology, Duke University, Durham, North Carolina.
  • Chen ST; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Chodosh J; Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
  • Cotliar J; Division of Dermatology, Harbor-University of California, Los Angeles Medical Center, Los Angeles, California.
  • Davis MDP; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • DeNiro KL; Division of Dermatology, University of Washington, Seattle, Washington.
  • Dominguez AR; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Eljure-Téllez J; Department of Dermatology, "Dr. Manuel Gea González" General Hospital, Mexico City, Mexico.
  • Femia A; Ronald O. Perelman Department of Dermatology, New York University Langone Health, New York, New York.
  • Fox LP; Department of Dermatology, University of California, San Francisco, California.
  • Guda A; University of Texas Health San Antonio Long School of Medicine, San Antonio, Texas.
  • Mitchell C; Vincent Center for Reproductive Biology, Department of Obstetrics, Gynecology & Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts.
  • Mostaghimi A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
  • Owen C; Division of Dermatology, Department of Medicine, University of Louisville, Louisville, Kentucky.
  • Pasieka H; Department of Dermatology, MedStar Washington Hospital Center, Washington, DC.
  • Rahnama-Moghadam S; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Saeed HN; Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
  • Saunderson RB; Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Shanbhag S; Tej Kohli Cornea Institute, L.V. Prasad Eye Institute, Hyderabad, India.
  • Sharon VR; Department of Dermatology, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
  • Strowd L; Department of Dermatology, Wake Forest University School of Medicine, Wake Forest, North Carolina.
  • Venkatesh S; Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Wanat KA; Department of Dermatology, University of Southern California, Los Angeles, California.
  • Wetter DA; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
  • Worswick S; Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Micheletti RG; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.
J Am Acad Dermatol ; 82(6): 1553-1567, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32151629
ABSTRACT
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening conditions with high morbidity and mortality. Supportive care management of SJS/TEN is highly variable. A systematic review of the literature was performed by dermatologists, ophthalmologists, intensivists, and gynecologists with expertise in SJS/TEN to generate statements for supportive care guideline development. Members of the Society of Dermatology Hospitalists with expertise in SJS/TEN were invited to participate in a modified, online Delphi-consensus. Participants were administered 9-point Likert scale questionnaires regarding 135 statements. The RAND/UCLA Appropriateness Method was used to evaluate and select proposed statements for guideline inclusion; statements with median ratings of 6.5 to 9 and a disagreement index of ≤1 were included in the guideline. For the final round, the guidelines were appraised by all of the participants. Included are an evidence-based discussion and recommendations for hospital setting and care team, wound care, ocular care, oral care, urogenital care, pain management, infection surveillance, fluid and electrolyte management, nutrition and stress ulcer prophylaxis, airway management, and anticoagulation in adult patients with SJS/TEN.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson Idioma: En Ano de publicação: 2020 Tipo de documento: Article